Found: 6
Select item for more details and to access through your institution.
Characterization of the Inflammatory Response to Severe COVID-19 Illness.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Ataluren, a New Therapeutic for Alpha-1 Antitrypsin-Deficient Individuals with Nonsense Mutations.
- Published in:
- 2018
- By:
- Publication type:
- Letter
Glycosylation Repurposes Alpha-1 Antitrypsin for Resolution of Community-acquired Pneumonia.
- Published in:
- 2018
- By:
- Publication type:
- Letter
The impact of alpha-1 antitrypsin augmentation therapy on neutrophil-driven respiratory disease in deficient individuals.
- Published in:
- Journal of Inflammation Research, 2018, v. 11, p. 123, doi. 10.2147/JIR.S156405
- By:
- Publication type:
- Article
Alpha-1 Antitrypsin Therapy Modifies Neutrophil Adhesion in Patients with Obstructive Lung Disease.
- Published in:
- American Journal of Respiratory Cell & Molecular Biology, 2022, v. 67, n. 1, p. 76, doi. 10.1165/rcmb.2021-0433OC
- By:
- Publication type:
- Article
Brief Report: Genetic Variation of the α<sub>1</sub>-Antitrypsin Gene Is Associated With Increased Autoantibody Production in Rheumatoid Arthritis.
- Published in:
- Arthritis & Rheumatology, 2017, v. 69, n. 8, p. 1576, doi. 10.1002/art.40127
- By:
- Publication type:
- Article